Ecthyma gangrenosum (Q38300): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
O ectima gangrenoso é uma infecção da pele com potencial risco de vida em pacientes imunocomprometidos por doença ou terapia imunossupressora. É mais comumente causada por Pseudomonas aeruginosa, embora uma variedade de outros organismos possam estar implicados. É caracterizada por máculas ou placas eritematosas geralmente indolores que progridem para formação de bolhas hemorrágicas e necrose da pele. As lesões podem ser múltiplas e amplamente disseminadas, embora a área anogenital seja um local comum. As Pseudomonas podem frequentemente ser cultivadas a partir do sangue. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Ecthyma gangrenosum is a potentially life-threatening infection of skin in patients who are immunocompromised through disease or immunosuppressive therapy. It is most commonly caused by Pseudomonas aeruginosa though a variety of other organisms may be implicated. It is characterised by usually painless erythematous macules or plaques which progress to haemorrhagic blistering and necrosis of the skin. Lesions may be multiple and widely disseminated, though the anogenital area is a common site. Pseudomonas can frequently be cultured from the blood. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1634854510 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:1B73.2 | |||||||||||||||
| Property / CURIE: CID11:1B73.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-1B73.2 | |||||||||||||||
| Property / Canary Token: dki-india-1B73.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: B08.0 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 03:15, 13 August 2026
Ecthyma gangrenosum is a potentially life-threatening infection of skin in patients who are immunocompromised through disease or immunosuppressive therapy. It is most commonly caused by Pseudomonas aeruginosa though a variety of other organisms may be implicated. It is characterised by usually painless erythematous macules or plaques which progress to haemorrhagic blistering and necrosis of the skin. Lesions may be multiple and widely disseminated, though the anogenital area is a common site. Pseudomonas can frequently be cultured from the blood.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 1B73.2 |
||
| English | Ecthyma gangrenosum |
Ecthyma gangrenosum is a potentially life-threatening infection of skin in patients who are immunocompromised through disease or immunosuppressive therapy. It is most commonly caused by Pseudomonas aeruginosa though a variety of other organisms may be implicated. It is characterised by usually painless erythematous macules or plaques which progress to haemorrhagic blistering and necrosis of the skin. Lesions may be multiple and widely disseminated, though the anogenital area is a common site. Pseudomonas can frequently be cultured from the blood. |
Statements
CID11:1B73.2
0 references
dki-india-1B73.2
0 references
Concluído
0 references
13 August 2026
0 references
